Bentham Science Logo

Track Your Manuscript:

Current Drug Targets

Volume 21, 16 Issues, 2020
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research


Current Drug Targets, Volume 19 - Number 3

Review Article

Review Article

Ion-Responsive Drug Delivery Systems

, 19(3): 225 - 238

Takayuki Yoshida*, Kohsuke Shakushiro and Kazuhiro Sako

DOI: 10.2174/1389450117666160527142138

Review Article

Functionalized Magnetic Nanostructures for Anticancer Therapy

, 19(3): 239 - 247

Eugenia Dumitra Teodor*, Florentina Gatea, Anton Ficai and Gabriel Lucian Radu

DOI: 10.2174/1389450117666160208145835

Review Article

Aptamer-Mediated Polymeric Vehicles for Enhanced Cell-Targeted Drug Delivery

, 19(3): 248 - 258

Kei X. Tan, Michael K. Danquah*, Amandeep Sidhu, Lau Sie Yon and Clarence M. Ongkudon

DOI: 10.2174/1389450117666160617120926

Review Article

Review Article

Review Article

The Application of Nanomaterials in Stem Cell Therapy for Some Neurological Diseases

, 19(3): 279 - 298

Guilong Zhang, Ahsan Ali Khan, Hao Wu, Lukui Chen*, Yuchun Gu and Ning Gu

DOI: 10.2174/1389450118666170328115801


Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556

View Full Editorial Board

COPE Compliant

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63


How to write and publish your papers in high impact journalsPLANNING YOUR RESEARCH TO PUBLISH IN HIGH IMPACT JOURNALSCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog